title: Phase I Trial: SABR and Ipilimumab-Response.
authors.affiliation: Departments of Radiation Oncology and Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, Texas. ctang1@mdanderson.org.
authors.forename: Chad
authors.initials: C
authors.lastname: Tang
authors.affiliation: Departments of Radiation Oncology and Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, Texas.
authors.forename: James W
authors.initials: JW
authors.lastname: Welsh
authors.affiliation: Departments of Radiation Oncology and Investigational Cancer Therapeutics, MD Anderson Cancer Center, Houston, Texas.
authors.forename: David
authors.initials: D
authors.lastname: Hong
mesh_terms: D006801:Humans; D000074324:Ipilimumab; D008175:Lung Neoplasms / Q000601:surgery; D016634:Radiosurgery; D013601:T-Lymphocytes
chemical_list: D000074324:Ipilimumab